Type-I IFN (IFN-I) are highly pleiotropic cytokines known to modulate immune responses and play an early central role in mediating antiviral defenses. We have shown that IFN-I mediate transient upregulation of a distinct subset of lymphocyte surface activation markers on both B and T cells in vivo independent of cognate antigen: a state referred to as 'partial lymphocyte activation'. Here we investigated in vitro the possibility that partial lymphocyte activation may serve to lower the antigenspecific activation thresholds for T cells. We found that the kinetics of Ca 21 flux in T cells responding to TCR cross-linking was not enhanced in partially activated T cells. Furthermore, following TCR stimulation with anti-cluster of differentiation (CD) 3e, a lower proportion of partially activated than naive T cells proliferated. In contrast, the proliferation of partially activated and naive ovalbumin peptide (OVAp, SIINFEKL) specific CD8 1 T cells (OT-I CD8 1 T cells) was similar when stimulated with OVAp. Surprisingly, using an enzyme-linked immunospot (ELISPOT) assay for IFN-g secretion, we found that a higher number of partially activated OT-I CD8 1 T cells expressed effector functions than did naive OT-I CD8 1 T cells. This is most readily explained by an increased survival of activated antigen-specific CD8
Introduction IFN-I, comprising primarily a and b subtypes, are cytokines well established to be a crucial component in combating viral infections by inducing an antiviral state on cells to prevent virus replication (1) . Although, their antiviral activities are well established, the ability of IFN-I to modulate adaptive immune responses has gained considerable recent appreciation and attention. Our group has shown that IFN-I alone, independent of antigen, mediate the transient up-regulation of lymphocyte surface activation markers cluster of differentiation (CD) 69 (an immunoregulatory molecule expressed early following lymphocyte activation) and CD86 (a costimulatory molecules) but not CD25 [the a chain of the interleukin (IL)-2 receptor] in lymphocytes: a state referred to as 'partial lymphocyte activation' (2) . Interestingly, IFN-I, in vitro, have been shown to lower the requirement of antigen for B-cell receptor (BCR)-dependent B-cell responses (3). Curtsinger et al. (4, 5) have shown in two independent studies that either IFN-I or IL-12 is required for optimal activation of naive T cells. In light of these findings, we hypothesized that IFN-I-mediated partial lymphocyte activation may transiently serve to lower the antigen-specific activation thresholds of naive T cells.
Naive T-cell activation has been classically known to require two signals: the interaction of TCRs with cognate peptide-MHCs of APCs and the interaction of the T cell costimulatory receptors with members of B7 family on APCs (6) . Recent studies, however, have argued for the requirement of inflammatory cytokines, such as IFN-I or IL-12, as a distinct 'third signal' (4, 5) . Fully activated T cells have been known to up-regulate numerous cell surface activation markers (7) . Our group has shown that up-regulation of certain surface activation markers is not sufficient to characterize fully activated T cells since IFN-I alone are capable of inducing the up-regulation of CD69 and CD86 without causing T-cell proliferation (2) . Instead, the up-regulation of distinct activation markers such as CD25 is required to characterize fully activated T cells. Furthermore, fully activated T cells have been known to undergo multiple sequential events, such as activation of Src kinases, Ca 2+ flux into the T-cell cytosol and T cell proliferation, that allow for the development of T-cell effector functions (reviewed in (8) ). In this study, we report our investigations on the dependence of Ca 2+ influx, proliferation and IFN-c secretion on IFN-I-mediated partial activation of T cells to test our hypothesis.
Methods

Mice
All mice were bred in a specific pathogen-free environment at the John Curtin School of Medical Research (JCSMR), Canberra, Australia. Wild-type C57BL/6 mice were purchased from the Phenomics Facility of JCSMR and transgenic C57BL/6 OT-I mice were purchased from the Animal Resources Centre, Perth, Australia. Twelve-to 16-week-old age-matched female mice were used in all experiments. Animals were used under the guidelines of the Australian National University's Animal Experimental Ethics Committee.
Reagents, antibodies and synthetic peptides
Synthetic peptides (representing cytotoxic T-cell determinants) used include Ectromelia virus peptide (EVp, TSYKFESV) and OVAp (SIINFEKL); both these peptides are restricted by MHC-I (H-2K b ) molecules and were synthesized in the Biomolecular Resource Facility, JCSMR. Allophycocyaninconjugated anti-CD8a, PE-conjugated anti-CD69 or anti-CD86, fluoresceine-isothiocyanate-conjugated anti-CD4 or anti-CD44 and Fc receptor (FcR) block were all from BD Biosciences (San Jose, CA, USA); PE-conjugated anti-CD25 was from Caltag Laboratories (Burlingame, CA, USA). Mouse recombinant IFN-b (r-IFN-b) was from PBL Biomedical Laboratories (Piscataway, NJ, USA). 7-Aminoactinomycin D (7-AAD), 4-(6-carboxy-2-indolyl)-4#-methyl-2, 2#-(ethylenedioxy) dianiline-N, N, N#, N#-tetraacetic acid tetrakis (acetomethyl) ester (Indo-1 AM) and mitomycin C were from Sigma-Aldrich (Saint Louis, MO, USA). Purified anti-CD3e and anti-Armenian hamster IgG were from Biologend (San Diego, CA, USA) and Jackson ImmunoResearch Laboratories (West Grove, PA, USA), respectively. Con A was from Amersham Pharmacia (Hemel Hempstead, UK) and carboxyfluorescein succinimidyl ester (CFSE) was from Molecular Probes (Eugene, OR, USA).
Incubation of splenocytes with r-IFN-b
In all assays conducted, RBC-depleted splenocytes from three mice, resuspended in Eagle's complete medium containing 10% FCS, were incubated at 1000 U ml À1 r-IFN-b or with PBS (mock) for 12 h at 37°C + 5% CO 2 using a starting cell concentration of 1.0 3 10 7 cells ml
À1
. Splenocytes were then stained for flow cytometry.
Measurement of Ca 2+ influxes
Wild-type C57BL/6 splenocytes were resuspended in cellloading medium [CLM: 97% RPMI-1640, 2% FCS, 1% HEPES (1 mM, pH 7.4), 0.1% PSN] at a concentration of 2 3 10 7 cells ml À1 and labeled with Indo-1 AM (1.5 lM) for 20 min at 37°C. Splenocytes were then surface stained using the indicated antibodies and anti-CD3e was added at the indicated concentrations. Prior to data acquisition, the Indo-1 AM bound:free ratio was set to one. The samples were then acquired in the following order: (i) 60 s baseline (no treatment), (ii) 180 s after addition of anti-Armenian hamster IgG and (iii) 60 s after addition of ionomycin. Ca 2+ bound or unbound to Indo-1 AM was detected using the fluorescence channels FL5 and FL4 of a Becton Dickinson LSR I (BD Biosciences), respectively. Splenocyte samples were resuspended in CLM at a cell concentration of 5.0 3 10 6 cells ml À1 and maintained at 37°C during data acquisition.
CFSE-staining and cell proliferation assay RBC-depleted wild-type C57BL/6 splenocytes were labeled using 5 lM CFSE as described (9) . The CFSE-labeled splenocytes were resuspended at 2.0 3 10 5 cells per well and cultured for 48 h at 37°C + 5% CO 2 in U-bottom well plates coated with anti-CD3e antibodies or mock treated. Splenocyte aliquots were removed at indicated time points from the cultures and analyzed using flow cytometry.
Measuring IFN-c secretion of OT-I CD8
+ T cells RBC-depleted OT-I splenocytes were labeled with 5 lM CFSE, resuspended in F15 complete medium containing 10% FCS and cultured at 37°C + 5% CO 2 after being supplemented with either 10 À5 M OVAp, 10 À8 M OVAp or 10
À5
M EVp. Following initial culture period of 24 h at 37°C + 5% CO 2 , excess peptide was removed by washing three times. Splenocytes were recultured in F15 complete medium containing 10% FCS for a further 5 days. After 48 h of culture, splenocyte aliquots from the cultures were analyzed using flow cytometry to measure CFSE dye dilution. After 5 days of culture, frequencies of IFN-c-secreting cells were determined by an ELISPOT assay following stimulation with mitomycin C-treated wild-type C57BL/6 splenocytes pulsed with peptides.
Graphs and statistical analysis
FACS plots and Ca 2+ flux kinetics plots were constructed using FlowJo (version 8.7.1) Treestar software. All graphs were constructed using GraphPad PRISM (version 4.0a). A student's unpaired t-test was used to determine statistical significance of the data.
Results
Exposure to r-IFN-b induces a surface phenotype of partial activation in T cells
The levels of partial activation of T cells as a result of in vitro exposure to r-IFN-b was determined using FACS to measure the cell surface expression of CD69, CD86 and CD25. Splenocytes from naive wild-type C57BL/6 mice were incubated in vitro in the presence of 1000 U ml À1 r-IFN-b or 758 IFN-I do not modulate activation of CD8 + T cells PBS (mock). After 12 h of incubation, splenocytes were stained for cell surface expression of activation markers and analyzed by FACS. Our data show that exposure of splenocytes to r-IFN-b induces the up-regulation of CD69 and CD86 but not CD25 in both CD4 + and CD8 + lymphocytes ( Fig. 1 and Table 1 ). Hence, these findings suggest that CD4 + and CD8 + T cells became partially activated in response to r-IFN-b treatment.
Although one may speculate that partial activation preferentially occurred in CD44hi resting memory T cells over 
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CD44lo naive T cells in the r-IFN-b-exposed splenocyte cultures, this appeared not to be the case. First, CD44hi cells only comprise ;20% of CD4 + T cells and ;11% of CD8 + T cells in the naive mice we have used in our experiments (Supplementary Table 1 is available at International Immunology Online), whereas a much greater proportion of T cells up-regulate activation markers following r-IFN-b exposure in vitro (Fig. 1) . Thus, a considerable proportion of CD44lo naive T cells must also be susceptible to partial activation by IFN-I. This was indeed the case as we also found that high percentage of both CD44lo and CD44hi T cells were partially activated following r-IFN-b exposure (Supplementary Figure 1B and C and Supplementary  Table 2 are available at International Immunology Online). In the following, expression of CD69 on T cells after IFN-I stimulation was chosen as the marker for partial activation. (Fig. 2) . Furthermore, the area under the curve of these traces as measured using FlowJo showed no statistically significant differences between the two treatment groups (data not shown). However, since activation markers are not universally expressed on r-IFN-b-treated splenocytes (Fig. 1) , we hypothesized that there may be functional differences between partially activated (CD69 + ) and non-activated (CD69 À ) splenocytes in the same r-IFN-b-treated population. For this purpose, splenocytes from r-IFN-b-treated cultures were labeled for CD4, CD8 and CD69 and Ca 2+ flux kinetics of CD69 + (partially activated) and CD69 À (naive) T cells were compared following TCR stimulation with titrated amounts of anti-CD3e. Surprisingly, CD69
+ T (both CD4 + and CD8 + ) cells had a lower magnitude of Ca + flux than CD69 À T cells (Fig. 3A-D) .
Partial activation does not affect the proliferative potential of OT-I CD8 + T cells but has antiproliferative effects on polyclonal T cells in vitro T-cell proliferation is temporally an intermediate event that occurs after naive T-cell activation. To investigate the dependence of T-cell proliferation on IFN-I-mediated partial activation of T cells, we compared the proliferative response of r-IFN-b-treated and naive polyclonal T cells following TCR stimulation with titrated amounts of plate-bound anti-CD3e. Wild-type C57BL/6 splenocytes from r-IFN-b-treated or mocktreated cultures were labeled with CFSE and recultured in the presence of either 3, 1 or 0 lg ml À1 of anti-CD3e for 2 days. Cells were then stained for CD4, CD8 and CD25 prior to FACS analysis. We found that a higher percentage of mocktreated polyclonal T cells (CD4 + and CD8 + ) committed to proliferation ( Fig. 4C and D) and underwent more rounds of divisions ( Fig. 4A and B ) than r-IFN-b-treated T cells. Despite these marked differences in proliferation, CD25 expression of mock-treated or r-IFN-b-treated CD8 + T cells was similar (Fig. 4E) , suggesting that these populations did not differ in their responsiveness to endogenous IL-2 produced. Similar results were obtained following polyclonal stimulation with 5 lg ml À1 of Con A (data not shown). ) and ionomycin (2 lg ml À1 ) were added at indicated time points. Results represent one of three splenocyte cultures tested per condition. This experiment was repeated three times with similar results.
IFN-I do not modulate activation of CD8 + T cells
In contrast to the findings with polyclonal T cells, partial activation resulting from r-IFN-b treatment had no impact on the proliferation of monoclonal OT-I CD8 + T cells pulsed with their cognate peptide antigen (OVAp). r-IFN-b treatment was able to mediate partial activation of OT-I CD8 + T cells (data not shown) similarly to that shown for polyclonal CD8 + T cells in Fig. 1 . Splenocytes from OT-I mice were r-IFN-b treated or mock treated for 12 h, then labeled with CFSE and recultured by supplementing OVAp or control peptides (EVp) for 2 days. Splenocytes were then stained for CD8 and CD25 prior to FACS analysis. While there were no statistically significant differences in the total proportion of divided CD8
+ cells between r-IFN-b-treated and mock-treated groups, a significantly higher proportion of mock-treated CD8 + cells underwent two divisions (at 10 À5 1and 10 À8 M OVAp; Tables 2 and 3 ) compared with r-IFN-b-treated CD8 + cells (Fig. 5A) . A very low proportion of CD8 + cells was seen to commit to three rounds of division in all cultures primed with OVAp (Tables 2 and 3 ). Similar to that observed with polyclonal CD8 + T cells, CD25 expression of OT-I CD8 + T cells following priming was 
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+ T cells 761 + cells that have up-regulated CD25 following TCR stimulation with titrated amounts of anti-CD3e. The data shown here represents the mean of splenocytes from three splenocyte cultures tested per condition. The error bars depict the standard error of the mean. A student's unpaired t-test was used to determine the P-values. This experiment was repeated three times with similar results.
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unaffected by partially activation prior to priming (Fig. 5B ). Proliferation and CD25 expression of OT-I CD8 + T cells was virtually absent in cultures stimulated with control EVp (Fig. 5) . Therefore, we conclude that partial activation does not affect the proliferative potential of OT-I CD8 + T cells following incubation with their cognate peptide, but partial activation (or IFN-I treatment) has antiproliferative effects on polyclonal T cells following polyclonal stimulation in vitro.
IFN-I-treated OT-I CD8 + T cells survive better and develop effector function more efficiently than untreated cells
The signaling events that occur upon naive T-cell activation culminate in the development of effector functions. To investigate the dependence of effector function development on partial activation, the number of IFN-c-secreting cells in r-IFN-b-treated and naive OT-I splenocyte cultures was quantified using an ELISPOT assay following priming and challenge with target cells pulsed with titrated amounts of OVAp or control EVp in vitro.
Partial activation before in vitro stimulation led to the development of a higher percentage of IFN-c-secreting cells following culture with 10 À5 M OVAp, but no differences in the percentage of IFN-c secreting cells was observed following culture with 10 À8 M OVAp for 5 days (Fig. 6A and B) . A higher number of IFN-c-secreting cells were detected in all partially activated cultures compared with mock cultures that were stimulated with OVAp for 5 days (Fig. 6C and D) . IFN-c-secreting cells were not detected in cultures incubated with control EVp (data not shown). Despite similar proportions of live OT-I CD8 + T cells having undergone cell division on day 2 (Fig. 5A) , the total proportion of live cells was dramatically different in r-IFN-b-treated and -untreated cultures on day 5 following priming with OVAp. Almost 10-fold more live CD8 + T cells were found in r-IFN-b-treated cultures than mock cultures in this instance (Fig. 6E) .
Discussion
IFN-I is known to induce systemic, transient and partial T-cell activation, independent of cognate antigen (2), but the physiological relevance of this phenomenon is currently not known. Given that IFN-I can reduce the requirement of antigen for B-cell activation to take place (3), we hypothesized that partial activation mediated by IFN-I may also lower the antigen-specific activation thresholds for T cells. In the present study, we examined this possibility by investigating early (Ca 2+ influxes), intermediate (proliferation) and late (IFN-c secretion) T-cell activation events by comparing the responses of partially activated T cells with resting T cells. Surprisingly, our investigations in vitro suggest that partial activation either does not modulate or actually increases the activation thresholds of T cells. Nevertheless, partially activated CD8
+ T cells survived better and developed into effector cells more efficiently.
Our findings suggest that naive T cells are susceptible to partial activation when exposed to IFN-I in vitro (Fig. 1) , which is consistent with our in vivo studies (2) . Furthermore, we also found that high percentages of both CD44lo naive T cells and CD44hi resting memory T cells were partially activated following in vitro IFN-I exposure, suggesting that partial activation does not preferentially occur on CD44hi T cells (Supplementary Figure 1 and Supplementary Table 2 (Fig. 2) . We also examined whether differences in the Ca 2+ flux kinetics of partially activated and naive T cells could be observed on a single cell basis by gating for CD69 + (partially activated) and CD69 À (naive) T cells in IFN-I-treated cultures. Surprisingly, gated CD69 + T cells have lower magnitude of Ca 2+ fluxes than CD69 À T cells following anti-TCR stimulation (Fig. 3) , indicating that the partial activation phenotype may actually comprise T cells that have increased rather than reduced their activation threshold. However, a caveat to this interpretation is that anti-CD69 mAbs have been shown to induce extracellular Ca 2+ to flux into the T-cell cytosol upon ligation with the cell surface CD69 receptor of T cells (11, 12) . The extracellular Ca 2+ that enters the T-cell cytosol could act to replenish the intracellular Ca 2+ stores that deplete after T-cell activation (in the present case after treatment with anti-CD3e). Therefore, + 7-AAD À splenocytes in these cultures determined by FACS was used to calculate the total number of live CD8 + T cells in all cultures. The data shown represent the mean of splenocytes from a total of three splenocyte cultures tested per condition. The error bars represent the standard error of the mean. A student's unpaired t-test was used to determine the P-values. This experiment was repeated three times with similar results.
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does not apply to partially activated polyclonal T cells since they had a reduced proliferative potential compared with naive T cells in response to anti-TCR stimulation (Fig. 4) . This is in agreement with a reported in vitro antiproliferative effect of IFN-I (14) . The factors that contribute to such an effect are currently not known. Furthermore, the greater proportion of non-dividing T cells found in the IFN-Iexposed cultures (Fig. 4) may be an in vitro correlate of the refractory period these cells go through following IFN-I exposure in vivo, which we have recently reported (15) . Since IFN-I mediate the up-regulation of activation markers, CD69 and CD86 but not CD25, the in vitro antiproliferative effect observed might be a consequence of IFN-I downregulating CD25 expression of partially activated T cells, thereby limiting responsiveness to IL-2 that might be produced during culture. However, this appeared not to be the case as cell surface CD25 expression on partially activated and naive polyclonal CD8 + T cells was similar following anti-TCR stimulation (Fig. 4E) . Similarly, CD25 expression was also similar on partially activated and naive transgenic OT-I CD8 + T cells following peptide stimulation with OVAp (Fig. 5B) .
Since IFN-I is required for efficient clonal expansion of CD8 + T cells in vivo (14) , the detected antiproliferative effect of IFN-I-treated polyclonal T cells may be exclusively an in vitro effect that can be overridden by recognition of cognate antigen. We have shown that both partially activated and naive OT-I CD8 + T cells proliferate similarly upon stimulation with OVAp (Fig. 5) . This suggests that recognition of antigen in the context of MHC molecules is sufficient to override any possible IFN-I-mediated antiproliferative effects on T cells. It has been reported that T-cell responses resulting from anti-CD3e stimulation may differ from those resulting from presentation of cognate antigen by APCs (16, 17) . This reinforces the notion that the type of stimuli used and its ability to mimic physiologically relevant modes of T-cell activation may significantly affect in vitro T-cell responses.
As a late event of T-cell activation, cognate peptidedependent IFN-c secretion by effector OT-I CD8 + T cells was examined. Surprisingly, our ELISPOT data suggest that a higher proportion of partially activated OT-I CD8 + T cells had developed effector functions than naive OT-I CD8 + T cells following stimulation with OVAp ( Fig. 6A-D) . Considering that there was no difference in the percentage of proliferating OT-I CD8 + T cells in partially activated and naive splenocyte cultures stimulated with OVAp at 2 days of culture, there appears to be no deficiency in the capacity of naive OT-I CD8 + T cells to be fully activated. Hence, the increased number of IFN-c-secreting cells in partially activated cultures is not likely to be the result of partial activation lowering the thresholds for activation of OT-I CD8 + T cells, but it is most probably due to a survival advantage that partial activation provides to OT-I CD8 + T cells. IFN-I have been reported to promote the survival of activated lymphocytes as illustrated by the significant increase in total live OT-I CD8 + T cells in bulk cultures on day 5 after stimulation with OVAp (Fig. 6E) . In conclusion, our investigation provides evidence that in contrast to B cells, IFN-I-mediated partial activation does not have any regulatory effect on the activation thresholds of T cells. It still remains to be determined why IFN-I have such a different impact on B versus T cells. Our study has shown that partial activation may prolong the survival of activated antigen-specific CD8 + T cells. This observation also supports recent in vivo studies that show that IFN-I are critical for survival of CD8
+ T cells following viral infections (14, 20) . The prolonged survival of activated CD8
+ T cells may allow for a more potent effector CD8 + T-cell response against viruses and it may also allow for the development of increased numbers of memory CD8 + T cells.
Supplementary data
Supplementary figure and tables 1 and 2 are available at International Immunology Online.
